The U.S. Food and Drug Administration recently gave the go-ahead to two new drugs, Xeljanz and Quillivant XR, to treat rheumatoid arthritis and Attention Deficit Hyperactivity Disorder, respectively, the manufacturing companies announced in separate statements.
The Food and Drug Administration has issued a stern warning to pharmaceutical manufacturer Warner Chilcott Company, LLC in Fajardo for not taking sufficient corrective action related to its birth control pill production.
Drugs produced in U.S.-owned and operated pharmaceutical manufacturing plants in Puerto Rico are more likely to have quality problems than those produced by the same firm in a matched plant on the mainland, a study released Tuesday by Ohio State University's Fisher College of Business.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
